Publications by authors named "Heather Litman"

Claim this Profile
D
Development and External Validation of a Multivariable Predictive Model for Progression to Difficult-to-Treat Rheumatoid Arthritis in Biologic-Experienced Patients.
Misti L Paudel, Nancy Shadick, Michael Weinblatt, George Reed, Heather J Litman

Arthritis Care Res (Hoboken)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applying Bias Correction Methods to Build Hybrid Controls Using Real-World Patients for a Phase IIb Randomized Controlled Trial of Baricitinib for Rheumatoid Arthritis.
Heather J Litman, Kristin M Sheffield, Oksana Pugach, Mingyang Shan, Paul Lakin

Pharm Stat· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease activity of rheumatoid arthritis and kidney function decline: a large prospective registry study.
Sho Fukui, Wolfgang C Winkelmayer, Sara K Tedeschi, Javier Marrugo, Hongshu Guan, Heather J Litman

Ann Rheum Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns in the Sequential Treatment of Patients With Rheumatoid Arthritis Starting a Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drug: 10-Year Experience From a US-Based Registry.
Anton Matsson, Daniel H Solomon, Margaux M Crabtree, Ryan W Harrison, Heather J Litman

ACR Open Rheumatol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing clusters of comorbidities in rheumatoid arthritis: a machine learning approach.
Daniel H Solomon, Hongshu Guan, Fredrik D Johansson, Leah Santacroce, Wendi Malley, Heather Litman

Arthritis Res Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns in the sequential treatment of rheumatoid arthritis patients starting a b/tsDMARD: 10-year experience from a US-based registry.
Anton Matsson, Daniel H Solomon, Margaux M Crabtree, Ryan W Harrison, Heather J Litman

Res Sq· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fracture in clinical studies of tofacitinib in rheumatoid arthritis.
Karen E Hansen, Mahta Mortezavi, Edward Nagy, Cunshan Wang, Carol A Connell, Heather J Litman

Ther Adv Musculoskelet Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the change in disease severity based on depressive symptoms in real-world psoriasis patients.
Neda Shahriari, Sarah Mattessich, Tin-Chi Lin, Heather J Litman, Robert R McLean

J Comp Eff Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of real-world patients with psoriasis and without a history of depression: The Corrona Psoriasis Registry.
Neda Shahriari, Tin-Chi Lin, Heather J Litman, Blessing Dube, Robert R McLean

J Am Acad Dermatol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postapproval Comparative Safety Study of Tofacitinib and Biological Disease-Modifying Antirheumatic Drugs: 5-Year Results from a United States-Based Rheumatoid Arthritis Registry.
Joel M Kremer, Clifton O Bingham, Laura C Cappelli, Jeffrey D Greenberg, Ann M Madsen, Heather J Litman

ACR Open Rheumatol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence on biologic DMARD monotherapy after achieving rheumatoid arthritis disease control on combination therapy: retrospective analysis of corrona registry data.
Dimitrios A Pappas, Heather J Litman, Tamara Lesperance, Greg Kricorian, Elaine Karis

Rheumatol Int· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of Patients with Psoriasis Treated with Apremilast in the Corrona Psoriasis Registry.
Alice B Gottlieb, Joseph F Merola, Joshua Cirulli, Catherine C Williams, Gregory J Linowski, Heather J Litman

Dermatol Ther (Heidelb)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Evidence to Contextualize Clinical Trial Results and Inform Regulatory Decisions: Tofacitinib Modified-Release Once-Daily vs Immediate-Release Twice-Daily for Rheumatoid Arthritis.
Stanley B Cohen, Jeffrey D Greenberg, James Harnett, Ann Madsen, Timothy W Smith, Heather J Litman

Adv Ther· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longterm, Real-world Safety of Adalimumab in Rheumatoid Arthritis: Analysis of a Prospective US-based Registry.
Leslie R Harrold, Jenny Griffith, Patrick Zueger, Heather J Litman, Bernice Gershenson

J Rheumatol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
US real-world effectiveness of secukinumab for the treatment of psoriasis: 6-month analysis from the Corrona Psoriasis Registry.
Bruce E Strober, Rebecca Germino, Adriana Guana, Jeffrey D Greenberg, Heather J Litman

J Dermatolog Treat· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing disease severity in bio-naïve patients with RA on treatment with csDMARDs: insights from the Corrona Registry.
Leslie R Harrold, Pankaj A Patel, Jenny Griffith, Heather J Litman, Hua Feng

Clin Rheumatol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Effectiveness of Abatacept Versus Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis Who Are Anti-CCP Positive in the United States Corrona Registry.
Leslie R Harrold, Heather J Litman, Sean E Connolly, Evo Alemao, Sheila Kelly

Rheumatol Ther· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intimate Partner Relationships, Work-Life Factors, and Their Associations With Burnout Among Partnered Pediatric Residents.
Selin Tuysuzoglu Sagalowsky, Angela M Feraco, Tamara E Baer, Heather J Litman, David N Williams

Acad Pediatr· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do Poor Prognostic Factors in Rheumatoid Arthritis Affect Treatment Choices and Outcomes? Analysis of a US Rheumatoid Arthritis Registry.
Evo Alemao, Heather J Litman, Sean E Connolly, Sheila Kelly, Winnie Hua

J Rheumatol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed Treatment Acceleration in Patients with Rheumatoid Arthritis Who Have Inadequate Response to Initial Tumor Necrosis Factor Inhibitors: Data from the Corrona Registry.
Dimitrios A Pappas, Robert A Gerber, Heather J Litman, David Gruben, Jamie Geier

Am Health Drug Benefits· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Anticitrullinated Protein Antibody Status on Response to Abatacept or Antitumor Necrosis Factor-α Therapy in Patients with Rheumatoid Arthritis: A US National Observational Study.
Leslie R Harrold, Heather J Litman, Sean E Connolly, Sheila Kelly, Winnie Hua

J Rheumatol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-year risk of serious infection in patients treated with certolizumab pegol as compared with other TNF inhibitors in a real-world setting: data from a national U.S. rheumatoid arthritis registry.
Leslie R Harrold, Heather J Litman, Katherine C Saunders, Kimberly J Dandreo, Bernice Gershenson

Arthritis Res Ther· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A window of opportunity for abatacept in RA: is disease duration an independent predictor of low disease activity/remission in clinical practice?
Leslie R Harrold, Heather J Litman, Sean E Connolly, Sheila Kelly, Winnie Hua

Clin Rheumatol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis.
Basavaraj Kerur, Heather J Litman, Julia Bender Stern, Sarah Weber, Jenifer R Lightdale

World J Gastroenterol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and demographic factors associated with change and maintenance of disease severity in a large registry of patients with rheumatoid arthritis.
George W Reed, David H Collier, Andrew S Koenig, Katherine C Saunders, Dimitrios A Pappas, Heather J Litman

Arthritis Res Ther· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis